Advertisement

Topics

NeuralStem Company Profile

01:23 EDT 19th August 2018 | BioPortfolio

Scientific founder and Chairman, Karl Johe, Ph.D. while at NINDS, NIH, originally developed Neuralstem’s technology. The Company’s other founders are current President & CEO Richard Garr, JD, and Merrill Solomon. The Company was founded in 1996.

Location

9700 Great Seneca Highway
Rockville
MD
20850
United States of America

Contact

Phone: 301.366.4960
Fax: 301-330-1055
Email: neuralsteminfo@neuralstem.com


News Articles [24 Associated News Articles listed on BioPortfolio]

Neuralstem Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 23042018] Prices from USD $350

Neuralstem Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Neuralstem Inc Mergers Acquisitions MA, Partnerships Alliances and Investments report inclu...

Neuralstem Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 30032018] Prices from USD $350

Neuralstem Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Neuralstem Inc Mergers Acquisitions MA, Partnerships Alliances and Investments report inclu...

CORRECTING and REPLACING -- Neuralstem, Inc.

GERMANTOWN, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) -- In a release issued yesterday by Neuralstem, Inc. (Nasdaq:CUR), please note the headline should be, "Neuralstem Announces Initiation of Phase 2 C...

Neuralstem to Participate at Upcoming Investor Conferences

GERMANTOWN, Md., March 12, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that member...

Neuralstem to Participate at the BIO 2018 International Convention

GERMANTOWN, Md., May 29, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Karl Johe,...

Neuralstem (CUR) Presents At ARM's 6th Cell & Gene Therapy Investor Day - Slideshow

Neuralstem Appoints Jim Scully as Interim Chief Executive Officer

GERMANTOWN, Md., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell an...

Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-189 in Ischemic Stroke

GERMANTOWN, Md., July 31, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell te...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

NeuralStem

Scientific founder and Chairman, Karl Johe, Ph.D. while at NINDS, NIH, originally developed Neuralstem’s technology. The Company’s other founders are current President & CEO Richard Garr, JD, and...

Neuralstem Inc.

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the d...

Neuralstem, Inc.

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability...

More Information about "NeuralStem" on BioPortfolio

We have published hundreds of NeuralStem news stories on BioPortfolio along with dozens of NeuralStem Clinical Trials and PubMed Articles about NeuralStem for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeuralStem Companies in our database. You can also find out about relevant NeuralStem Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record